Acemetacin is a carboxylic ester that is the carboxymethyl ester of indometacin. A non-steroidal anti-inflammatory drug, it is used in the treatment of rheumatoid arthritis, osteoarthritis, and low back pain, as well as for postoperative pain and inflammation.

Market Analysis and Insights: Global Acemetacin (CAS 53164-05-9) Market

Due to the COVID-19 pandemic, the global Acemetacin (CAS 53164-05-9) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, 98% Purity Type accounting for % of the Acemetacin (CAS 53164-05-9) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Asimicin Capsule (30mg) segment is altered to an % CAGR throughout this forecast period.

Acemetacin has proven effective in the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and other kinds of rheumatoid inflammation, as well as in post-operative and post-traumatic pain and attack of gout.

Global Acemetacin (CAS 53164-05-9) Scope and Segment

Acemetacin (CAS 53164-05-9) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Acemetacin (CAS 53164-05-9) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

98% Purity Type

99% Purity Type

Others

Segment by Application

Asimicin Capsule (30mg)

Asimexin Sustained Release Capsule (90mg)

BY COMPANY

3B Scientific

CSPC

DC Chemicals

OChem

Adooq BioScience

Clearsynth

Angene Chemical

Vlada Chem

AbMole Bioscience

MuseChem

AHH Chemical

Jiangmin Taihua Chemical

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

FEATURED COMPANIES

Jiangmin Taihua Chemical

1 Study Coverage

1.1 Acemetacin (CAS 53164-05-9) Product Introduction

1.2 Market by Type

1.2.1 Global Acemetacin (CAS 53164-05-9) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 98% Purity Type

1.2.3 99% Purity Type

1.2.4 Others

1.3 Market by Application

1.3.1 Global Acemetacin (CAS 53164-05-9) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Asimicin Capsule (30mg)

1.3.3 Asimexin Sustained Release Capsule (90mg)

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Acemetacin (CAS 53164-05-9) Sales Estimates and Forecasts 2017-2028

2.2 Global Acemetacin (CAS 53164-05-9) Revenue Estimates and Forecasts 2017-2028

2.3 Global Acemetacin (CAS 53164-05-9) Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Acemetacin (CAS 53164-05-9) Sales by Region

2.4.1 Global Acemetacin (CAS 53164-05-9) Sales by Region (2017-2022)

2.4.2 Global Sales Acemetacin (CAS 53164-05-9) by Region (2023-2028)

2.5 Global Acemetacin (CAS 53164-05-9) Revenue by Region

2.5.1 Global Acemetacin (CAS 53164-05-9) Revenue by Region (2017-2022)

2.5.2 Global Acemetacin (CAS 53164-05-9) Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Acemetacin (CAS 53164-05-9) Sales by Manufacturers

3.1.1 Global Top Acemetacin (CAS 53164-05-9) Manufacturers by Sales (2017-2022)

3.1.2 Global Acemetacin (CAS 53164-05-9) Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Acemetacin (CAS 53164-05-9) in 2021

3.2 Global Acemetacin (CAS 53164-05-9) Revenue by Manufacturers

3.2.1 Global Acemetacin (CAS 53164-05-9) Revenue by Manufacturers (2017-2022)

3.2.2 Global Acemetacin (CAS 53164-05-9) Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Acemetacin (CAS 53164-05-9) Revenue in 2021

3.3 Global Acemetacin (CAS 53164-05-9) Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Acemetacin (CAS 53164-05-9) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Acemetacin (CAS 53164-05-9) Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Acemetacin (CAS 53164-05-9) Sales by Type

4.1.1 Global Acemetacin (CAS 53164-05-9) Historical Sales by Type (2017-2022)

4.1.2 Global Acemetacin (CAS 53164-05-9) Forecasted Sales by Type (2023-2028)

4.1.3 Global Acemetacin (CAS 53164-05-9) Sales Market Share by Type (2017-2028)

4.2 Global Acemetacin (CAS 53164-05-9) Revenue by Type

4.2.1 Global Acemetacin (CAS 53164-05-9) Historical Revenue by Type (2017-2022)

4.2.2 Global Acemetacin (CAS 53164-05-9) Forecasted Revenue by Type (2023-2028)

4.2.3 Global Acemetacin (CAS 53164-05-9) Revenue Market Share by Type (2017-2028)

4.3 Global Acemetacin (CAS 53164-05-9) Price by Type

4.3.1 Global Acemetacin (CAS 53164-05-9) Price by Type (2017-2022)

4.3.2 Global Acemetacin (CAS 53164-05-9) Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Acemetacin (CAS 53164-05-9) Sales by Application

5.1.1 Global Acemetacin (CAS 53164-05-9) Historical Sales by Application (2017-2022)

5.1.2 Global Acemetacin (CAS 53164-05-9) Forecasted Sales by Application (2023-2028)

5.1.3 Global Acemetacin (CAS 53164-05-9) Sales Market Share by Application (2017-2028)

5.2 Global Acemetacin (CAS 53164-05-9) Revenue by Application

5.2.1 Global Acemetacin (CAS 53164-05-9) Historical Revenue by Application (2017-2022)

5.2.2 Global Acemetacin (CAS 53164-05-9) Forecasted Revenue by Application (2023-2028)

5.2.3 Global Acemetacin (CAS 53164-05-9) Revenue Market Share by Application (2017-2028)

5.3 Global Acemetacin (CAS 53164-05-9) Price by Application

5.3.1 Global Acemetacin (CAS 53164-05-9) Price by Application (2017-2022)

5.3.2 Global Acemetacin (CAS 53164-05-9) Price Forecast by Application (2023-2028)

6 North America

6.1 North America Acemetacin (CAS 53164-05-9) Market Size by Type

6.1.1 North America Acemetacin (CAS 53164-05-9) Sales by Type (2017-2028)

6.1.2 North America Acemetacin (CAS 53164-05-9) Revenue by Type (2017-2028)

6.2 North America Acemetacin (CAS 53164-05-9) Market Size by Application

6.2.1 North America Acemetacin (CAS 53164-05-9) Sales by Application (2017-2028)

6.2.2 North America Acemetacin (CAS 53164-05-9) Revenue by Application (2017-2028)

6.3 North America Acemetacin (CAS 53164-05-9) Market Size by Country

6.3.1 North America Acemetacin (CAS 53164-05-9) Sales by Country (2017-2028)

6.3.2 North America Acemetacin (CAS 53164-05-9) Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Acemetacin (CAS 53164-05-9) Market Size by Type

7.1.1 Europe Acemetacin (CAS 53164-05-9) Sales by Type (2017-2028)

7.1.2 Europe Acemetacin (CAS 53164-05-9) Revenue by Type (2017-2028)

7.2 Europe Acemetacin (CAS 53164-05-9) Market Size by Application

7.2.1 Europe Acemetacin (CAS 53164-05-9) Sales by Application (2017-2028)

7.2.2 Europe Acemetacin (CAS 53164-05-9) Revenue by Application (2017-2028)

7.3 Europe Acemetacin (CAS 53164-05-9) Market Size by Country

7.3.1 Europe Acemetacin (CAS 53164-05-9) Sales by Country (2017-2028)

7.3.2 Europe Acemetacin (CAS 53164-05-9) Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Acemetacin (CAS 53164-05-9) Market Size by Type

8.1.1 Asia Pacific Acemetacin (CAS 53164-05-9) Sales by Type (2017-2028)

8.1.2 Asia Pacific Acemetacin (CAS 53164-05-9) Revenue by Type (2017-2028)

8.2 Asia Pacific Acemetacin (CAS 53164-05-9) Market Size by Application

8.2.1 Asia Pacific Acemetacin (CAS 53164-05-9) Sales by Application (2017-2028)

8.2.2 Asia Pacific Acemetacin (CAS 53164-05-9) Revenue by Application (2017-2028)

8.3 Asia Pacific Acemetacin (CAS 53164-05-9) Market Size by Region

8.3.1 Asia Pacific Acemetacin (CAS 53164-05-9) Sales by Region (2017-2028)

8.3.2 Asia Pacific Acemetacin (CAS 53164-05-9) Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Acemetacin (CAS 53164-05-9) Market Size by Type

9.1.1 Latin America Acemetacin (CAS 53164-05-9) Sales by Type (2017-2028)

9.1.2 Latin America Acemetacin (CAS 53164-05-9) Revenue by Type (2017-2028)

9.2 Latin America Acemetacin (CAS 53164-05-9) Market Size by Application

9.2.1 Latin America Acemetacin (CAS 53164-05-9) Sales by Application (2017-2028)

9.2.2 Latin America Acemetacin (CAS 53164-05-9) Revenue by Application (2017-2028)

9.3 Latin America Acemetacin (CAS 53164-05-9) Market Size by Country

9.3.1 Latin America Acemetacin (CAS 53164-05-9) Sales by Country (2017-2028)

9.3.2 Latin America Acemetacin (CAS 53164-05-9) Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Acemetacin (CAS 53164-05-9) Market Size by Type

10.1.1 Middle East and Africa Acemetacin (CAS 53164-05-9) Sales by Type (2017-2028)

10.1.2 Middle East and Africa Acemetacin (CAS 53164-05-9) Revenue by Type (2017-2028)

10.2 Middle East and Africa Acemetacin (CAS 53164-05-9) Market Size by Application

10.2.1 Middle East and Africa Acemetacin (CAS 53164-05-9) Sales by Application (2017-2028)

10.2.2 Middle East and Africa Acemetacin (CAS 53164-05-9) Revenue by Application (2017-2028)

10.3 Middle East and Africa Acemetacin (CAS 53164-05-9) Market Size by Country

10.3.1 Middle East and Africa Acemetacin (CAS 53164-05-9) Sales by Country (2017-2028)

10.3.2 Middle East and Africa Acemetacin (CAS 53164-05-9) Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 3B Scientific

11.1.1 3B Scientific Corporation Information

11.1.2 3B Scientific Overview

11.1.3 3B Scientific Acemetacin (CAS 53164-05-9) Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 3B Scientific Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 3B Scientific Recent Developments

11.2 CSPC

11.2.1 CSPC Corporation Information

11.2.2 CSPC Overview

11.2.3 CSPC Acemetacin (CAS 53164-05-9) Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 CSPC Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 CSPC Recent Developments

11.3 DC Chemicals

11.3.1 DC Chemicals Corporation Information

11.3.2 DC Chemicals Overview

11.3.3 DC Chemicals Acemetacin (CAS 53164-05-9) Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 DC Chemicals Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 DC Chemicals Recent Developments

11.4 OChem

11.4.1 OChem Corporation Information

11.4.2 OChem Overview

11.4.3 OChem Acemetacin (CAS 53164-05-9) Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 OChem Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 OChem Recent Developments

11.5 Adooq BioScience

11.5.1 Adooq BioScience Corporation Information

11.5.2 Adooq BioScience Overview

11.5.3 Adooq BioScience Acemetacin (CAS 53164-05-9) Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Adooq BioScience Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Adooq BioScience Recent Developments

11.6 Clearsynth

11.6.1 Clearsynth Corporation Information

11.6.2 Clearsynth Overview

11.6.3 Clearsynth Acemetacin (CAS 53164-05-9) Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Clearsynth Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Clearsynth Recent Developments

11.7 Angene Chemical

11.7.1 Angene Chemical Corporation Information

11.7.2 Angene Chemical Overview

11.7.3 Angene Chemical Acemetacin (CAS 53164-05-9) Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Angene Chemical Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Angene Chemical Recent Developments

11.8 Vlada Chem

11.8.1 Vlada Chem Corporation Information

11.8.2 Vlada Chem Overview

11.8.3 Vlada Chem Acemetacin (CAS 53164-05-9) Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Vlada Chem Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Vlada Chem Recent Developments

11.9 AbMole Bioscience

11.9.1 AbMole Bioscience Corporation Information

11.9.2 AbMole Bioscience Overview

11.9.3 AbMole Bioscience Acemetacin (CAS 53164-05-9) Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 AbMole Bioscience Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 AbMole Bioscience Recent Developments

11.10 MuseChem

11.10.1 MuseChem Corporation Information

11.10.2 MuseChem Overview

11.10.3 MuseChem Acemetacin (CAS 53164-05-9) Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 MuseChem Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 MuseChem Recent Developments

11.11 AHH Chemical

11.11.1 AHH Chemical Corporation Information

11.11.2 AHH Chemical Overview

11.11.3 AHH Chemical Acemetacin (CAS 53164-05-9) Sales, Price, Revenue and Gross Margin (2017-2022)

11.11.4 AHH Chemical Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 AHH Chemical Recent Developments

11.12 Jiangmin Taihua Chemical

11.12.1 Jiangmin Taihua Chemical Corporation Information

11.12.2 Jiangmin Taihua Chemical Overview

11.12.3 Jiangmin Taihua Chemical Acemetacin (CAS 53164-05-9) Sales, Price, Revenue and Gross Margin (2017-2022)

11.12.4 Jiangmin Taihua Chemical Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Jiangmin Taihua Chemical Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Acemetacin (CAS 53164-05-9) Industry Chain Analysis

12.2 Acemetacin (CAS 53164-05-9) Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Acemetacin (CAS 53164-05-9) Production Mode & Process

12.4 Acemetacin (CAS 53164-05-9) Sales and Marketing

12.4.1 Acemetacin (CAS 53164-05-9) Sales Channels

12.4.2 Acemetacin (CAS 53164-05-9) Distributors

12.5 Acemetacin (CAS 53164-05-9) Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Acemetacin (CAS 53164-05-9) Industry Trends

13.2 Acemetacin (CAS 53164-05-9) Market Drivers

13.3 Acemetacin (CAS 53164-05-9) Market Challenges

13.4 Acemetacin (CAS 53164-05-9) Market Restraints

14 Key Findings in The Global Acemetacin (CAS 53164-05-9) Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Jiangmin Taihua Chemical

List of Tables

Table 1. Global Acemetacin (CAS 53164-05-9) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of 98% Purity Type

Table 3. Major Manufacturers of 99% Purity Type

Table 4. Major Manufacturers of Others

Table 5. Global Acemetacin (CAS 53164-05-9) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 6. Global Acemetacin (CAS 53164-05-9) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 7. Global Acemetacin (CAS 53164-05-9) Sales by Region (2017-2022) & (Kg)

Table 8. Global Acemetacin (CAS 53164-05-9) Sales Market Share by Region (2017-2022)

Table 9. Global Acemetacin (CAS 53164-05-9) Sales by Region (2023-2028) & (Kg)

Table 10. Global Acemetacin (CAS 53164-05-9) Sales Market Share by Region (2023-2028)

Table 11. Global Acemetacin (CAS 53164-05-9) Revenue by Region (2017-2022) & (US$ Million)

Table 12. Global Acemetacin (CAS 53164-05-9) Revenue Market Share by Region (2017-2022)

Table 13. Global Acemetacin (CAS 53164-05-9) Revenue by Region (2023-2028) & (US$ Million)

Table 14. Global Acemetacin (CAS 53164-05-9) Revenue Market Share by Region (2023-2028)

Table 15. Global Acemetacin (CAS 53164-05-9) Sales by Manufacturers (2017-2022) & (Kg)

Table 16. Global Acemetacin (CAS 53164-05-9) Sales Share by Manufacturers (2017-2022)

Table 17. Global Acemetacin (CAS 53164-05-9) Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 18. Global Acemetacin (CAS 53164-05-9) Revenue Share by Manufacturers (2017-2022)

Table 19. Acemetacin (CAS 53164-05-9) Price by Manufacturers (2017-2022) &(USD/Kg)

Table 20. Global Acemetacin (CAS 53164-05-9) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 21. Global Acemetacin (CAS 53164-05-9) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acemetacin (CAS 53164-05-9) as of 2021)

Table 22. Acemetacin (CAS 53164-05-9) Manufacturing Base Distribution and Headquarters

Table 23. Manufacturers Acemetacin (CAS 53164-05-9) Product Offered

Table 24. Date of Manufacturers Enter into Acemetacin (CAS 53164-05-9) Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Acemetacin (CAS 53164-05-9) Sales by Type (2017-2022) & (Kg)

Table 27. Global Acemetacin (CAS 53164-05-9) Sales by Type (2023-2028) & (Kg)

Table 28. Global Acemetacin (CAS 53164-05-9) Sales Share by Type (2017-2022)

Table 29. Global Acemetacin (CAS 53164-05-9) Sales Share by Type (2023-2028)

Table 30. Global Acemetacin (CAS 53164-05-9) Revenue by Type (2017-2022) & (US$ Million)

Table 31. Global Acemetacin (CAS 53164-05-9) Revenue by Type (2023-2028) & (US$ Million)

Table 32. Global Acemetacin (CAS 53164-05-9) Revenue Share by Type (2017-2022)

Table 33. Global Acemetacin (CAS 53164-05-9) Revenue Share by Type (2023-2028)

Table 34. Acemetacin (CAS 53164-05-9) Price by Type (2017-2022) & (USD/Kg)

Table 35. Global Acemetacin (CAS 53164-05-9) Price Forecast by Type (2023-2028) & (USD/Kg)

Table 36. Global Acemetacin (CAS 53164-05-9) Sales by Application (2017-2022) & (Kg)

Table 37. Global Acemetacin (CAS 53164-05-9) Sales by Application (2023-2028) & (Kg)

Table 38. Global Acemetacin (CAS 53164-05-9) Sales Share by Application (2017-2022)

Table 39. Global Acemetacin (CAS 53164-05-9) Sales Share by Application (2023-2028)

Table 40. Global Acemetacin (CAS 53164-05-9) Revenue by Application (2017-2022) & (US$ Million)

Table 41. Global Acemetacin (CAS 53164-05-9) Revenue by Application (2023-2028) & (US$ Million)

Table 42. Global Acemetacin (CAS 53164-05-9) Revenue Share by Application (2017-2022)

Table 43. Global Acemetacin (CAS 53164-05-9) Revenue Share by Application (2023-2028)

Table 44. Acemetacin (CAS 53164-05-9) Price by Application (2017-2022) & (USD/Kg)

Table 45. Global Acemetacin (CAS 53164-05-9) Price Forecast by Application (2023-2028) & (USD/Kg)

Table 46. North America Acemetacin (CAS 53164-05-9) Sales by Type (2017-2022) & (Kg)

Table 47. North America Acemetacin (CAS 53164-05-9) Sales by Type (2023-2028) & (Kg)

Table 48. North America Acemetacin (CAS 53164-05-9) Revenue by Type (2017-2022) & (US$ Million)

Table 49. North America Acemetacin (CAS 53164-05-9) Revenue by Type (2023-2028) & (US$ Million)

Table 50. North America Acemetacin (CAS 53164-05-9) Sales by Application (2017-2022) & (Kg)

Table 51. North America Acemetacin (CAS 53164-05-9) Sales by Application (2023-2028) & (Kg)

Table 52. North America Acemetacin (CAS 53164-05-9) Revenue by Application (2017-2022) & (US$ Million)

Table 53. North America Acemetacin (CAS 53164-05-9) Revenue by Application (2023-2028) & (US$ Million)

Table 54. North America Acemetacin (CAS 53164-05-9) Sales by Country (2017-2022) & (Kg)

Table 55. North America Acemetacin (CAS 53164-05-9) Sales by Country (2023-2028) & (Kg)

Table 56. North America Acemetacin (CAS 53164-05-9) Revenue by Country (2017-2022) & (US$ Million)

Table 57. North America Acemetacin (CAS 53164-05-9) Revenue by Country (2023-2028) & (US$ Million)

Table 58. Europe Acemetacin (CAS 53164-05-9) Sales by Type (2017-2022) & (Kg)

Table 59. Europe Acemetacin (CAS 53164-05-9) Sales by Type (2023-2028) & (Kg)

Table 60. Europe Acemetacin (CAS 53164-05-9) Revenue by Type (2017-2022) & (US$ Million)

Table 61. Europe Acemetacin (CAS 53164-05-9) Revenue by Type (2023-2028) & (US$ Million)

Table 62. Europe Acemetacin (CAS 53164-05-9) Sales by Application (2017-2022) & (Kg)

Table 63. Europe Acemetacin (CAS 53164-05-9) Sales by Application (2023-2028) & (Kg)

Table 64. Europe Acemetacin (CAS 53164-05-9) Revenue by Application (2017-2022) & (US$ Million)

Table 65. Europe Acemetacin (CAS 53164-05-9) Revenue by Application (2023-2028) & (US$ Million)

Table 66. Europe Acemetacin (CAS 53164-05-9) Sales by Country (2017-2022) & (Kg)

Table 67. Europe Acemetacin (CAS 53164-05-9) Sales by Country (2023-2028) & (Kg)

Table 68. Europe Acemetacin (CAS 53164-05-9) Revenue by Country (2017-2022) & (US$ Million)

Table 69. Europe Acemetacin (CAS 53164-05-9) Revenue by Country (2023-2028) & (US$ Million)

Table 70. Asia Pacific Acemetacin (CAS 53164-05-9) Sales by Type (2017-2022) & (Kg)

Table 71. Asia Pacific Acemetacin (CAS 53164-05-9) Sales by Type (2023-2028) & (Kg)

Table 72. Asia Pacific Acemetacin (CAS 53164-05-9) Revenue by Type (2017-2022) & (US$ Million)

Table 73. Asia Pacific Acemetacin (CAS 53164-05-9) Revenue by Type (2023-2028) & (US$ Million)

Table 74. Asia Pacific Acemetacin (CAS 53164-05-9) Sales by Application (2017-2022) & (Kg)

Table 75. Asia Pacific Acemetacin (CAS 53164-05-9) Sales by Application (2023-2028) & (Kg)

Table 76. Asia Pacific Acemetacin (CAS 53164-05-9) Revenue by Application (2017-2022) & (US$ Million)

Table 77. Asia Pacific Acemetacin (CAS 53164-05-9) Revenue by Application (2023-2028) & (US$ Million)

Table 78. Asia Pacific Acemetacin (CAS 53164-05-9) Sales by Region (2017-2022) & (Kg)

Table 79. Asia Pacific Acemetacin (CAS 53164-05-9) Sales by Region (2023-2028) & (Kg)

Table 80. Asia Pacific Acemetacin (CAS 53164-05-9) Revenue by Region (2017-2022) & (US$ Million)

Table 81. Asia Pacific Acemetacin (CAS 53164-05-9) Revenue by Region (2023-2028) & (US$ Million)

Table 82. Latin America Acemetacin (CAS 53164-05-9) Sales by Type (2017-2022) & (Kg)

Table 83. Latin America Acemetacin (CAS 53164-05-9) Sales by Type (2023-2028) & (Kg)

Table 84. Latin America Acemetacin (CAS 53164-05-9) Revenue by Type (2017-2022) & (US$ Million)

Table 85. Latin America Acemetacin (CAS 53164-05-9) Revenue by Type (2023-2028) & (US$ Million)

Table 86. Latin America Acemetacin (CAS 53164-05-9) Sales by Application (2017-2022) & (Kg)

Table 87. Latin America Acemetacin (CAS 53164-05-9) Sales by Application (2023-2028) & (Kg)

Table 88. Latin America Acemetacin (CAS 53164-05-9) Revenue by Application (2017-2022) & (US$ Million)

Table 89. Latin America Acemetacin (CAS 53164-05-9) Revenue by Application (2023-2028) & (US$ Million)

Table 90. Latin America Acemetacin (CAS 53164-05-9) Sales by Country (2017-2022) & (Kg)

Table 91. Latin America Acemetacin (CAS 53164-05-9) Sales by Country (2023-2028) & (Kg)

Table 92. Latin America Acemetacin (CAS 53164-05-9) Revenue by Country (2017-2022) & (US$ Million)

Table 93. Latin America Acemetacin (CAS 53164-05-9) Revenue by Country (2023-2028) & (US$ Million)

Table 94. Middle East and Africa Acemetacin (CAS 53164-05-9) Sales by Type (2017-2022) & (Kg)

Table 95. Middle East and Africa Acemetacin (CAS 53164-05-9) Sales by Type (2023-2028) & (Kg)

Table 96. Middle East and Africa Acemetacin (CAS 53164-05-9) Revenue by Type (2017-2022) & (US$ Million)

Table 97. Middle East and Africa Acemetacin (CAS 53164-05-9) Revenue by Type (2023-2028) & (US$ Million)

Table 98. Middle East and Africa Acemetacin (CAS 53164-05-9) Sales by Application (2017-2022) & (Kg)

Table 99. Middle East and Africa Acemetacin (CAS 53164-05-9) Sales by Application (2023-2028) & (Kg)

Table 100. Middle East and Africa Acemetacin (CAS 53164-05-9) Revenue by Application (2017-2022) & (US$ Million)

Table 101. Middle East and Africa Acemetacin (CAS 53164-05-9) Revenue by Application (2023-2028) & (US$ Million)

Table 102. Middle East and Africa Acemetacin (CAS 53164-05-9) Sales by Country (2017-2022) & (Kg)

Table 103. Middle East and Africa Acemetacin (CAS 53164-05-9) Sales by Country (2023-2028) & (Kg)

Table 104. Middle East and Africa Acemetacin (CAS 53164-05-9) Revenue by Country (2017-2022) & (US$ Million)

Table 105. Middle East and Africa Acemetacin (CAS 53164-05-9) Revenue by Country (2023-2028) & (US$ Million)

Table 106. 3B Scientific Corporation Information

Table 107. 3B Scientific Description and Major Businesses

Table 108. 3B Scientific Acemetacin (CAS 53164-05-9) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 109. 3B Scientific Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

Table 110. 3B Scientific Recent Developments

Table 111. CSPC Corporation Information

Table 112. CSPC Description and Major Businesses

Table 113. CSPC Acemetacin (CAS 53164-05-9) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 114. CSPC Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

Table 115. CSPC Recent Developments

Table 116. DC Chemicals Corporation Information

Table 117. DC Chemicals Description and Major Businesses

Table 118. DC Chemicals Acemetacin (CAS 53164-05-9) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 119. DC Chemicals Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

Table 120. DC Chemicals Recent Developments

Table 121. OChem Corporation Information

Table 122. OChem Description and Major Businesses

Table 123. OChem Acemetacin (CAS 53164-05-9) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 124. OChem Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

Table 125. OChem Recent Developments

Table 126. Adooq BioScience Corporation Information

Table 127. Adooq BioScience Description and Major Businesses

Table 128. Adooq BioScience Acemetacin (CAS 53164-05-9) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 129. Adooq BioScience Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

Table 130. Adooq BioScience Recent Developments

Table 131. Clearsynth Corporation Information

Table 132. Clearsynth Description and Major Businesses

Table 133. Clearsynth Acemetacin (CAS 53164-05-9) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 134. Clearsynth Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

Table 135. Clearsynth Recent Developments

Table 136. Angene Chemical Corporation Information

Table 137. Angene Chemical Description and Major Businesses

Table 138. Angene Chemical Acemetacin (CAS 53164-05-9) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 139. Angene Chemical Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

Table 140. Angene Chemical Recent Developments

Table 141. Vlada Chem Corporation Information

Table 142. Vlada Chem Description and Major Businesses

Table 143. Vlada Chem Acemetacin (CAS 53164-05-9) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 144. Vlada Chem Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

Table 145. Vlada Chem Recent Developments

Table 146. AbMole Bioscience Corporation Information

Table 147. AbMole Bioscience Description and Major Businesses

Table 148. AbMole Bioscience Acemetacin (CAS 53164-05-9) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 149. AbMole Bioscience Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

Table 150. AbMole Bioscience Recent Developments

Table 151. MuseChem Corporation Information

Table 152. MuseChem Description and Major Businesses

Table 153. MuseChem Acemetacin (CAS 53164-05-9) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 154. MuseChem Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

Table 155. MuseChem Recent Developments

Table 156. AHH Chemical Corporation Information

Table 157. AHH Chemical Description and Major Businesses

Table 158. AHH Chemical Acemetacin (CAS 53164-05-9) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 159. AHH Chemical Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

Table 160. AHH Chemical Recent Developments

Table 161. Jiangmin Taihua Chemical Corporation Information

Table 162. Jiangmin Taihua Chemical Description and Major Businesses

Table 163. Jiangmin Taihua Chemical Acemetacin (CAS 53164-05-9) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 164. Jiangmin Taihua Chemical Acemetacin (CAS 53164-05-9) Product Model Numbers, Pictures, Descriptions and Specifications

Table 165. Jiangmin Taihua Chemical Recent Developments

Table 166. Key Raw Materials Lists

Table 167. Raw Materials Key Suppliers Lists

Table 168. Acemetacin (CAS 53164-05-9) Distributors List

Table 169. Acemetacin (CAS 53164-05-9) Customers List

Table 170. Acemetacin (CAS 53164-05-9) Market Trends

Table 171. Acemetacin (CAS 53164-05-9) Market Drivers

Table 172. Acemetacin (CAS 53164-05-9) Market Challenges

Table 173. Acemetacin (CAS 53164-05-9) Market Restraints

Table 174. Research Programs/Design for This Report

Table 175. Key Data Information from Secondary Sources

Table 176. Key Data Information from Primary Sources

List of Figures

Figure 1. Acemetacin (CAS 53164-05-9) Product Picture

Figure 3. Global Acemetacin (CAS 53164-05-9) Market Share by Type in 2021 & 2028

Figure 3. 98% Purity Type Product Picture

Figure 4. 99% Purity Type Product Picture

Figure 5. Others Product Picture

Figure 6. Global Acemetacin (CAS 53164-05-9) Market Share by Application in 2021 & 2028

Figure 7. Asimicin Capsule (30mg)

Figure 8. Asimexin Sustained Release Capsule (90mg)

Figure 9. Acemetacin (CAS 53164-05-9) Report Years Considered

Figure 10. Global Acemetacin (CAS 53164-05-9) Sales 2017-2028 (Kg)

Figure 11. Global Acemetacin (CAS 53164-05-9) Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 12. Global Acemetacin (CAS 53164-05-9) Revenue 2017-2028 (US$ Million)

Figure 13. Global Acemetacin (CAS 53164-05-9) Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 14. Global Acemetacin (CAS 53164-05-9) Sales Market Share by Region (2017-2022)

Figure 15. Global Acemetacin (CAS 53164-05-9) Sales Market Share by Region (2023-2028)

Figure 16. North America Acemetacin (CAS 53164-05-9) Sales YoY (2017-2028) & (Kg)

Figure 17. North America Acemetacin (CAS 53164-05-9) Revenue YoY (2017-2028) & (US$ Million)

Figure 18. Europe Acemetacin (CAS 53164-05-9) Sales YoY (2017-2028) & (Kg)

Figure 19. Europe Acemetacin (CAS 53164-05-9) Revenue YoY (2017-2028) & (US$ Million)

Figure 20. Asia-Pacific Acemetacin (CAS 53164-05-9) Sales YoY (2017-2028) & (Kg)

Figure 21. Asia-Pacific Acemetacin (CAS 53164-05-9) Revenue YoY (2017-2028) & (US$ Million)

Figure 22. Latin America Acemetacin (CAS 53164-05-9) Sales YoY (2017-2028) & (Kg)

Figure 23. Latin America Acemetacin (CAS 53164-05-9) Revenue YoY (2017-2028) & (US$ Million)

Figure 24. Middle East & Africa Acemetacin (CAS 53164-05-9) Sales YoY (2017-2028) & (Kg)

Figure 25. Middle East & Africa Acemetacin (CAS 53164-05-9) Revenue YoY (2017-2028) & (US$ Million)

Figure 26. The Acemetacin (CAS 53164-05-9) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 27. The Top 5 and 10 Largest Manufacturers of Acemetacin (CAS 53164-05-9) in the World: Market Share by Acemetacin (CAS 53164-05-9) Revenue in 2021

Figure 28. Global Acemetacin (CAS 53164-05-9) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 29. Global Acemetacin (CAS 53164-05-9) Sales Market Share by Type (2017-2028)

Figure 30. Global Acemetacin (CAS 53164-05-9) Revenue Market Share by Type (2017-2028)

Figure 31. Global Acemetacin (CAS 53164-05-9) Sales Market Share by Application (2017-2028)

Figure 32. Global Acemetacin (CAS 53164-05-9) Revenue Market Share by Application (2017-2028)

Figure 33. North America Acemetacin (CAS 53164-05-9) Sales Market Share by Type (2017-2028)

Figure 34. North America Acemetacin (CAS 53164-05-9) Revenue Market Share by Type (2017-2028)

Figure 35. North America Acemetacin (CAS 53164-05-9) Sales Market Share by Application (2017-2028)

Figure 36. North America Acemetacin (CAS 53164-05-9) Revenue Market Share by Application (2017-2028)

Figure 37. North America Acemetacin (CAS 53164-05-9) Sales Share by Country (2017-2028)

Figure 38. North America Acemetacin (CAS 53164-05-9) Revenue Share by Country (2017-2028)

Figure 39. U.S. Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 40. Canada Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 41. Europe Acemetacin (CAS 53164-05-9) Sales Market Share by Type (2017-2028)

Figure 42. Europe Acemetacin (CAS 53164-05-9) Revenue Market Share by Type (2017-2028)

Figure 43. Europe Acemetacin (CAS 53164-05-9) Sales Market Share by Application (2017-2028)

Figure 44. Europe Acemetacin (CAS 53164-05-9) Revenue Market Share by Application (2017-2028)

Figure 45. Europe Acemetacin (CAS 53164-05-9) Sales Share by Country (2017-2028)

Figure 46. Europe Acemetacin (CAS 53164-05-9) Revenue Share by Country (2017-2028)

Figure 47. Germany Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 48. France Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 49. U.K. Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 50. Italy Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 51. Russia Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 52. Asia Pacific Acemetacin (CAS 53164-05-9) Sales Market Share by Type (2017-2028)

Figure 53. Asia Pacific Acemetacin (CAS 53164-05-9) Revenue Market Share by Type (2017-2028)

Figure 54. Asia Pacific Acemetacin (CAS 53164-05-9) Sales Market Share by Application (2017-2028)

Figure 55. Asia Pacific Acemetacin (CAS 53164-05-9) Revenue Market Share by Application (2017-2028)

Figure 56. Asia Pacific Acemetacin (CAS 53164-05-9) Sales Share by Region (2017-2028)

Figure 57. Asia Pacific Acemetacin (CAS 53164-05-9) Revenue Share by Region (2017-2028)

Figure 58. China Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 59. Japan Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 60. South Korea Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 61. India Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 62. Australia Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 63. Taiwan Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 64. Indonesia Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 65. Thailand Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 66. Malaysia Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 67. Philippines Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 68. Latin America Acemetacin (CAS 53164-05-9) Sales Market Share by Type (2017-2028)

Figure 69. Latin America Acemetacin (CAS 53164-05-9) Revenue Market Share by Type (2017-2028)

Figure 70. Latin America Acemetacin (CAS 53164-05-9) Sales Market Share by Application (2017-2028)

Figure 71. Latin America Acemetacin (CAS 53164-05-9) Revenue Market Share by Application (2017-2028)

Figure 72. Latin America Acemetacin (CAS 53164-05-9) Sales Share by Country (2017-2028)

Figure 73. Latin America Acemetacin (CAS 53164-05-9) Revenue Share by Country (2017-2028)

Figure 74. Mexico Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 75. Brazil Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 76. Argentina Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 77. Middle East and Africa Acemetacin (CAS 53164-05-9) Sales Market Share by Type (2017-2028)

Figure 78. Middle East and Africa Acemetacin (CAS 53164-05-9) Revenue Market Share by Type (2017-2028)

Figure 79. Middle East and Africa Acemetacin (CAS 53164-05-9) Sales Market Share by Application (2017-2028)

Figure 80. Middle East and Africa Acemetacin (CAS 53164-05-9) Revenue Market Share by Application (2017-2028)

Figure 81. Middle East and Africa Acemetacin (CAS 53164-05-9) Sales Share by Country (2017-2028)

Figure 82. Middle East and Africa Acemetacin (CAS 53164-05-9) Revenue Share by Country (2017-2028)

Figure 83. Turkey Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 84. Saudi Arabia Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 85. U.A.E Acemetacin (CAS 53164-05-9) Revenue (2017-2028) & (US$ Million)

Figure 86. Acemetacin (CAS 53164-05-9) Value Chain

Figure 87. Acemetacin (CAS 53164-05-9) Production Process

Figure 88. Channels of Distribution

Figure 89. Distributors Profiles

Figure 90. Bottom-up and Top-down Approaches for This Report

Figure 91. Data Triangulation

Figure 92. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Acemetacin (CAS 53164-05-9) Market Insights, Forecast to 2028

Published Date: February 2022

Report Code: QYRE-Auto-10W7436

Global Acemetacin (CAS 53164-05-9) Market Insights, Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25N19924

Wed Dec 03 00:00:00 UTC 2025

120 Pages

Type: Report

Code: QYRE-Auto-24B19783

Fri Nov 28 00:00:00 UTC 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20305

Fri Nov 28 00:00:00 UTC 2025

120 Pages

Type: Report

Code: QYRE-Auto-12S20176

Mon Nov 24 00:00:00 UTC 2025

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions